How Tomorrow's Weather Could Predict Your Hospital's Mental Health Crisis Load
A decade-long analysis of 15 million NHS contacts reveals that daily weather fluctuations—from temperature swings to rainfall—significantly influence mental health service demand, opening new frontiers for AI-powered healthcare forecasting.
Andreessen Horowitz Bets Big on Spatial Biology with $50M Investment in 3D Disease Mapping Platform
Xellar's AI-powered platform combines 3D tissue imaging and spatial omics to create comprehensive biological maps that could revolutionize drug discovery and precision medicine.
RNA-Targeting Breakthrough: Ionis Scores Dual Wins with First-Ever FCS Therapy and $430M Licensing Deal
FDA approval of Tryngolza for ultra-rare pancreatitis disorder and major partnership for hereditary angioedema treatment signal growing confidence in antisense oligonucleotide technology.
Georgia Hospital Tackles Paramedic PTSD with Peer Counselors and a Four-Legged Therapist
By pairing peer counselors with therapy dogs, one Georgia health system is breaking the stigma around mental health in emergency medical services.
Why Your Hospital's AI Dreams May Be Failing Before They Start: The Infrastructure Gap No One Talks About
Most hospital AI projects fail not because the technology is flawed, but because foundational data infrastructure wasn't built first.
Healthcare's AI Darwinism: Why Most Hospitals Will Fail the Autonomous Revolution
Healthcare organizations face mounting pressure to adopt autonomous AI systems or risk competitive obsolescence in what industry observers describe as a technological survival test.
Dexcom Stelo OTC Continuous Glucose Monitor Reaches One Million Users
Dexcom has announced that its Stelo continuous glucose monitor — the first OTC CGM approved by the FDA — has reached one million users, with the majority being people without diabetes who are using the device for metabolic health optimization.